參考文獻(xiàn)/References:
[1] WANG T,AZEDDINE B,MAH W,et al.Osteonecrosis of the femoral head:genetic basis[J].Int Orthop,2019,43(3):519-530.
[2] ZHAO D W,YU M,HU K,et al.Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally re-presentative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[3] MONT M A,SALEM H S,PIUZZI N S,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today?:A 5-year update[J].J Bone Joint Surg Am,2020,102(12):1084-1099.
[4] MONT M A,ZYWIEL M G,MARKER D R,et al.The natural history of untreated of the femoral head:a systematic literature review[J].J Bone Joint Surg Am,2010,92(12):2165-2170.
[5] HUANG Z Q,FU F Y,LI W L,et al.Current treatment modalities for osteonecrosis of femoral head in mainland China:a cross-sectional study[J].Orthop Surg,2020,12(6):1776-1783.
[6] LI Z R,CHENG L M,WANG K Z,et al.Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head—a first multicentre,randomised,double-blind,placebo-controlled clinical trial[J].J Orthop Translat,2017,12:36-44.
[7] WEI Q S,HONG G J,YUAN Y J,et al.Huo Xue Tong Luo capsule,a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head:a prospective study[J].J Orthop Translat,2019,18:65-73.
[8] HUANG Z,FU F,YE H,et al.Chinese herbal Huo-Gu formula for the treatment of steroid-associated osteonecrosis of femoral head:a 14-year follow-up of convalescent SARS patients[J].J Orthop Translat,2020,23:122-131.
[9] MONT M A,MARULANDA G A,JONES L C,et al.Systematic analysis of classification systems for osteonecrosis of the femoral head[J].J Bone Joint Surg Am,2006,88(Suppl 3):16-26.
[10] 李子榮,劉朝暉,孫偉,等.基于三柱結(jié)構(gòu)的股骨頭壞死分型——中日友好醫(yī)院分型[J].中華骨科雜志,2012,32(6):515-520.
[11] 郭效東,陳衛(wèi)衡,趙永剛,等.股骨頭無菌性壞死三期辨證論治的臨床研究[J].中國骨傷,1995,8(6):19-20.
[12] 劉少軍,袁浩.股骨頭壞死的中醫(yī)臨床思路與方法探討[J].中國醫(yī)藥學(xué)報,2002,17(1):44-47.
[13] 何偉.如何把握股骨頭壞死患者的保髖治療時機(jī)[J].中國骨與關(guān)節(jié)雜志,2016,5(2):82-86.
[14] ZHANG Q Y,LI Z R,GAO F Q,et al.Pericollapse stage of osteonecrosis of the femoral head:a last chance for joint preservation[J].Chin Med J(Engl),2018,131(21):2589-2598.
[15] 陳衛(wèi)衡,劉道兵,張洪美,等.股骨頭壞死的三期四型辨證思路[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2003,9(12):51-52.
[16] 中華中醫(yī)藥學(xué)會.股骨頭壞死中醫(yī)辨證標(biāo)準(zhǔn)(2019年版)[J].中醫(yī)正骨,2019,31(6):1-2.
[17] 郭蕾,王永炎,張志斌.關(guān)于證候概念的詮釋[J].北京中醫(yī)藥大學(xué)學(xué)報,2003,26(2):5-8.
[18] 王旭東.辨證論治法則的歷史觀、辯證觀[J].中國醫(yī)藥學(xué)報,1988,3(1):53-55.
[19] 趙文,林雪娟,周常恩,等.中醫(yī)辨證的內(nèi)涵與外延[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2021,27(11):1689-1692.
[20] 原淳淳,王晶,舒冰,等.中醫(yī)表型組學(xué)的概念與相關(guān)研究體系的構(gòu)建[J].中醫(yī)雜志,2022,63(5):407-411.
[21] 左玲,陳建新,王偉,等.中醫(yī)信息學(xué)與表型組學(xué):癥狀的遺傳突變與證候的生物學(xué)基礎(chǔ)初探[J].北京中醫(yī)藥大學(xué)學(xué)報,2022,45(2):140-147.
[22] 張彥瓊,李梢.網(wǎng)絡(luò)藥理學(xué)與中醫(yī)藥現(xiàn)代研究的若干進(jìn)展[J].中國藥理學(xué)與毒理學(xué)雜志,2015,29(6):883-892.
[23] 許海玉,楊洪軍.整合藥理學(xué):中藥現(xiàn)代研究新模式[J].中國中藥雜志,2014,39(3):357-362.
[24] 蔡甜甜,潘華峰,王奇,等.中藥復(fù)方在病證基礎(chǔ)上的網(wǎng)絡(luò)藥理學(xué)研究[J].中華中醫(yī)藥雜志,2016,31(11):4746-4748.
[25] 李梢,王永炎,季梁,等.復(fù)雜系統(tǒng)意義下的中醫(yī)藥學(xué)及其案例研究[J].系統(tǒng)仿真學(xué)報,2002,14(11):1429-1431.
[26] 李泰賢,張彥瓊,薛志鵬,等.激素性股骨頭壞死不同中醫(yī)證候分型相關(guān)基因表達(dá)譜的鑒定及其候選標(biāo)志分子的發(fā)現(xiàn)與驗證[J].中華中醫(yī)藥雜志,2019,34(10):4536-4542.
[27] 李泰賢,張彥瓊,黃澤青,等.從分子網(wǎng)絡(luò)解析非創(chuàng)傷性股骨頭壞死不同中醫(yī)證候的生物學(xué)基礎(chǔ)及其對證方藥的作用機(jī)制[J].中國實驗方劑學(xué)雜志,2020,26(16):192-204.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達(dá)的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):20.
[11]張程,何海軍.中醫(yī)藥防治股骨頭壞死的優(yōu)勢與面臨的挑戰(zhàn)[J].中醫(yī)正骨,2023,35(11):60.